These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3921948)

  • 1. Confusion and paranoia associated with oral tocainide.
    Clarke CW; el-Mahdi EO
    Postgrad Med J; 1985 Jan; 61(711):79-81. PubMed ID: 3921948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe paranoia with concomitant tocainide and propranolol therapy.
    Rubino M; Jackson E
    Clin Pharm; 1982; 1(2):177-9. PubMed ID: 6821034
    [No Abstract]   [Full Text] [Related]  

  • 3. Paranoid psychoses induced by tocainide.
    Harrison DJ; Wathen CG
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):1010-1. PubMed ID: 6423157
    [No Abstract]   [Full Text] [Related]  

  • 4. Paranoid psychosis induced by tocainide.
    Currie P; Ramsdale DR
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):606-7. PubMed ID: 6421396
    [No Abstract]   [Full Text] [Related]  

  • 5. Mental changes associated with tocainide, a new antiarrhythmic.
    Bikadoroff S
    Can J Psychiatry; 1987 Apr; 32(3):219-21. PubMed ID: 3105861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose finding of tocainide in the treatment of tinnitus.
    Vermeij P; Hulshof JH
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):207-12. PubMed ID: 3086242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intra-venous lidocaine and several different doses oral tocainide HCl on tinnitus. A dose-finding study.
    Hulshof JH; Vermeij P
    Acta Otolaryngol; 1984; 98(3-4):231-8. PubMed ID: 6437131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus.
    Blayney AW; Phillips MS; Guy AM; Colman BH
    Clin Otolaryngol Allied Sci; 1985 Apr; 10(2):97-101. PubMed ID: 3928215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of tinnitus with tocainide hydrochloride.
    Emmett JR; Shea JJ
    Otolaryngol Head Neck Surg; 1980; 88(4):442-6. PubMed ID: 6821429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting patients from intravenous lidocaine to oral tocainide treatment.
    Zhanel GG; Bleske BE
    JAMA; 1986 Jun; 255(24):3361-2. PubMed ID: 3086579
    [No Abstract]   [Full Text] [Related]  

  • 12. Nodal bradycardia induced by tocainide.
    Mandal SK; Datta SK
    Postgrad Med J; 1983 Apr; 59(690):262-3. PubMed ID: 6408628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seizure induced by concurrent lidocaine-tocainide therapy--is it just a case of additive toxicity?
    Forrence E; Covinsky JO; Mullen C
    Drug Intell Clin Pharm; 1986 Jan; 20(1):56-9. PubMed ID: 3080299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on the seizure threshold in dogs of tocainide/lidocaine administration.
    Schuster MR; Paris PM; Kaplan RM; Stewart RD
    Ann Emerg Med; 1987 Jul; 16(7):749-51. PubMed ID: 3109286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tinnitus therapy with lidocaine and tocainide].
    Lenarz T; Gülzow J
    Laryngol Rhinol Otol (Stuttg); 1985 Dec; 64(12):604-8. PubMed ID: 3937005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocainide-induced reversible agranulocytosis and anemia.
    Soff GA; Kadin ME
    Arch Intern Med; 1987 Mar; 147(3):598-9. PubMed ID: 3103562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic rounds at the Milton S. Hershey Medical Center: central nervous system toxicity caused by lidocaine.
    Schneck DW
    Clin Ther; 1983; 5(6):579, 671-2. PubMed ID: 6627284
    [No Abstract]   [Full Text] [Related]  

  • 19. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tocainide in patients with severe renal failure.
    Braun J; Sörgel F; Engelmaier F; Gluth WP; Gessler U
    Eur J Clin Pharmacol; 1985; 28(6):665-70. PubMed ID: 3933983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.